1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with n-acetylsphingosine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inokuchi, J; Kuriyama, M; Mutoh, T; Tokuda, A | 1 |
Hirabayashi, Y; Inokuchi, J; Ito, M; Ji, L; Yamagata, T; Zhang, G | 1 |
Fukunaga, T; Hatsuzawa, K; Nagahama, M; Tagaya, M; Tani, K; Yamamoto, A | 1 |
Baccino, FM; Bonelli, G; Codogno, P; De Stefanis, D; Ghidoni, R; Isidoro, C; Reffo, P; Sala, G | 1 |
Colligan, PB; Relling, DP; Ren, J | 1 |
Abe, A; Hiraoka, M; Shayman, JA | 1 |
1 review(s) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and n-acetylsphingosine
Article | Year |
---|---|
A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity.
Topics: Acylation; Acyltransferases; Animals; Cattle; Ceramides; DNA, Complementary; Enzyme Inhibitors; Glucosyltransferases; Humans; Lysosomes; Mice; Molecular Structure; Morpholines; Phospholipases A; Phospholipases A2; Signal Transduction; Sphingosine | 2004 |
5 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and n-acetylsphingosine
Article | Year |
---|---|
Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells.
Topics: Animals; Cell Differentiation; Drosophila Proteins; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Gangliosides; Glucosyltransferases; Glycosphingolipids; Insect Proteins; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Morpholines; Nerve Growth Factors; Neurons; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Rats; Signal Transduction; Sphingosine | 1998 |
Effects of endoglycoceramidase or D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol on glucose uptake, glycolysis, and mitochondrial respiration in HL60 cells.
Topics: Cell Membrane Permeability; Cell Respiration; Glucose; Glycolysis; Glycoside Hydrolases; HL-60 Cells; Humans; Intracellular Fluid; Mitochondria; Morpholines; Oxidation-Reduction; Sphingosine | 1998 |
Implication of sphingolipid metabolism in the stability of the Golgi apparatus.
Topics: Animals; Brefeldin A; Cattle; Cell Line; Ceramides; Coat Protein Complex I; Endocannabinoids; Endosomes; Enzyme Inhibitors; Ethanolamines; Golgi Apparatus; Masoprocol; Microscopy, Electron; Morpholines; Nocodazole; Oleic Acids; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingosine; trans-Golgi Network | 2000 |
Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells.
Topics: Amide Synthases; Apoptosis; Caspase Inhibitors; Caspases; Cathepsin D; Ceramides; Cytochrome c Group; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; HT29 Cells; Humans; Immunoblotting; Lysosomes; Mitochondria; Morpholines; Nucleosomes; Sphingosine | 2002 |
Ceramide attenuates high glucose-induced cardiac contractile abnormalities in cultured adult rat ventricular myocytes.
Topics: Animals; Calcium; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Glucose; Heart Ventricles; Male; Morpholines; Muscle Cells; Myocardial Contraction; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Sphingosine | 2002 |